Trademark: 85075209
Status Date
Friday, December 29, 2017
Registration Number
3964974
Registration Date
Tuesday, May 24, 2011
Filing Date
Wednesday, June 30, 2010
Published for Opposition
Tuesday, March 8, 2011
Cancellation Date
Friday, December 29, 2017
5 Pharmaceuticals derived from recombinant DNA technology for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Dec 29, 2017
Cancelled Sec. 8 (6-Yr)
Jul 6, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 6, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 24, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 21, 2011
Teas Change Of Correspondence Received
May 24, 2011
Registered-Principal Register
Mar 8, 2011
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2011
Published For Opposition
Feb 3, 2011
Law Office Publication Review Completed
Feb 2, 2011
Approved For Pub - Principal Register
Feb 1, 2011
Amendment From Applicant Entered
Feb 1, 2011
Correspondence Received In Law Office
Jan 31, 2011
Paper Received
Sep 29, 2010
Notification Of Non-Final Action E-Mailed
Sep 29, 2010
Non-Final Action E-Mailed
Sep 29, 2010
Non-Final Action Written
Sep 26, 2010
Assigned To Examiner
Aug 17, 2010
Amendment From Applicant Entered
Aug 17, 2010
Correspondence Received In Law Office
Aug 10, 2010
Assigned To Lie
Jul 26, 2010
Paper Received
Jul 6, 2010
New Application Office Supplied Data Entered In Tram
Jul 3, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
